1Uemura T, Shepherd S, Ackerman L, et al. Numb, a gene required in determination of cell fate during sensory organ formation in Drosophilaembryos [ J ]. Cell, 1989, 58 (2) : 349-360.
2Rhyu MS, Jan LY, Jan YN. Asymmetric distribution of Numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells [ J ] . Cell, 1994, 76(3) :477 -491.
3Spana EP, Kopczynski C, Goodman CS, et al. Asymmetric localization of Numb autonomously determines sibling neuron identity in the Dro- sophila CNS [ J ]. Development, 1995,121(11) :3489-3494.
4Knoblich JA, Jan LY, Jan YN. Asymmetric segregation of Numb and prospero during cell division [ J ]. Nature, 1995,377 ( 6550 ) : 624 - 627.
5Bork P, Margolis B. A phosphotyrosine interaction domain [ J ]. Cell, 1995, 80(5) :693 -694.
6Frise E, Knoblich JA, Younger- Shepherd S. The Drosophila Numb protein inhibits signaling of the Notch receptor during cell- cell interaction in sensory organ lineage [ J ].Proc Natl Acad Sci USA, 1996, 15,93 (21) :11925 -11932.
7Knoblieh JA, Jan LY, Jan YN. The N terminus of the Drosophila Numb protein directs membrane association and actin-dependent asymmetric localization [ J ] . Proc Nail Acad Sci USA, 1997, 94(24) :13005 - 13010.
8Dho SE, Jacob S, Wolting CD, et al. The mammalian Numb phosphotyrosine - binding domain. Characterization of binding specificity and i- dentification of a novel PDZ domaincontaining numb binding protein, LNX[J]. J Biol Chem, 1998, 273(15) : 9179 -9187.
9Chien CT, Wang S, Rothenberg M, et al. Numb-associated kinase interacts with the phosphotyrosine binding domain of Numb and antagonizes the function of Numb in vivo[J]. Mol Cell Biol, 1998, 18 (1) :598 - 607.
10Wakamatsu Y, Maynard TM, Jones SU, et al. NUMB localizes in the basal cortex of mitotic avian neuroepithelial cells and modulates neuro- nal differentiation by binding to NOTCH-1 [ J] . Neuron, 1999,23 (1):71 -81.
同被引文献73
1Friel A M, Corcoran C, Crown J, 0;Driscoll L. Relevance of cir-culating tumor cells, extracellular nucleic acids and exosome inbreast cancer[J]. Breast Cancer Res Treat,2010,123(3) :613 -25.
2Tsang J C,Lo Y M. Circulating nucleic acids in plasma/serum[J]. Pathology, 2007,39(2) : 197-207.
3Chan A K, Chiu R W, Lo Y M. Cell-free nucleic acids in plas-ma ,serum and urine: a new tool in molecular diagnosis[ J]. AnnClin Biochem, 2003,40(pt2) :122 -30.
4Mostert B, Sieuwerts A M, Martens J W, Sleijfer S. Diagnosticapplications of cell-free and circulating tumor cell-associated miR-NAs in cancer patients[ J]. Expert Rev Mol Diagn,2011,11(3):259-75.
5Farazi T A, Spitzer J L, Monozov P, et al. miRNAs in humancancer[J]. J Pathol, 2011,223 : 102 - 15.
6Zhu W, Qin W, Atasoy U, Sauter E R. Circulating microRNAs inbreast cancer and healthy subjects[ J]. BMC Res Nots, 2009,2 :89.
7Roth C, Rack B, Muller V, et al. Circulating microRNAs asblood-based markers for patients with primary and Metastatic breastcancer [ J]. Breast Cancer Res, 2010,12(6) :R90.
8Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microR-IVA-21 concentrations in early and advanced breast cancer [ J].Clin Chem, 2011,57(1) :84-91.
9Heneghan H M,Miller N,Lowery A,et al. Circulating microRNAsas novel minimally invasive biomarkers for breast cancer [ J] . AnnSurg, 2010,251(3) :499 -505.
10Heneghan H M, Miller N, Kelly R, et al. Systemic miRNA-195differentiates breast cancer from other malignancies and is a potien-tial biomarker for detecting noninvasive and early stage disease[J]. Oncologist, 2010,15(7):673 -82.
